BRAZILIAN
Brazilian Finance Logo
FINANCE

MENU

© 2026 Brazilian Finance

Markets · Stocks & ETFs · ADR

SmartFit (OTC: SFEGY)

$13.74+0.00%today

Brazilian ADR trading on the OTC, priced in US dollars.

Display currency
Market Cap, EPS and the financial totals below — switch between US dollars and BRL.
Market Cap
$2.02B
P/E (TTM)
13.3x
P/B
1.8x
EPS (TTM)
$1.03
Dividend Yield
—
52-Week Range
$13.74 – $13.74
Volume
670
Previous Close
$13.74

TTM = trailing twelve months — the most recent 12 months (a rolling window), used for P/E, EPS and dividends. On the tables and charts below, the in-progress current year appears as a “Last 12M” column labelled with the quarter range it covers.

Performance

Today
+0.00%
1 Week
+0.00%
1 Month
+0.00%
YTD
+0.00%
1 Year
+0.00%
5 Years
—

About SmartFit

US Ticker
SFEGY
B3 Ticker
SMFT3
Exchange
OTC
Currency
USD
Sector
—
Industry
—
Headquarters
—
Employees
—
CEO
—
Founded
—

(Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.)

smartfit.com

Financial Results

Revenue, EBITDA and net profit (in USD) with net margin (net profit ÷ revenue).

Financial Health

Margins, leverage and cash-flow quality derived from SmartFit's income statement, balance sheet and cash flow (absolute figures in USD).

ProfitabilityLeverageGrowth

Overall: Financially Solid

Net Margin
8.8%
ROE
11.6%
Rev Growth (YoY)
+10.73%
Net Debt / EBITDA
2.86×
Current Ratio
1.20×
Interest Coverage
1.54×
Free Cash Flow
-639.4M
Payout Ratio
—

Income — Margins & Efficiency

MetricLast 12MQ3'25 – Q2'26Δ2025Δ2024Δ2023Δ2022
Revenue$1,549,568,671+17.2%$1,322,393,996+46.4%$903,268,748+3.2%$875,168,653+57.8%$554,524,089
Gross profit$674,329,720+20.0%$561,878,858+50.1%$374,381,262+6.1%$352,746,072+104.4%$172,580,895
Operating income$394,990,048+18.7%$332,801,030+51.2%$220,107,965+13.3%$194,267,041+233.5%$58,253,983
EBITDA$820,500,319+17.5%$698,104,525+46.9%$475,347,124-9.7%$526,318,502+83.3%$287,196,950
Net profit$135,689,798+16.3%$116,629,780+65.1%$70,645,365-66.9%$213,713,661+1362.9%-$16,922,946
Gross margin43.5%+1.0 p.p.42.5%+1.0 p.p.41.4%+1.1 p.p.40.3%+9.2 p.p.31.1%
Operating margin25.5%+0.3 p.p.25.2%+0.8 p.p.24.4%+2.2 p.p.22.2%+11.7 p.p.10.5%
EBITDA margin53.0%+0.2 p.p.52.8%+0.2 p.p.52.6%-7.5 p.p.60.1%+8.3 p.p.51.8%
Net margin8.8%-0.1 p.p.8.8%+1.0 p.p.7.8%-16.6 p.p.24.4%+27.5 p.p.-3.1%
Revenue growth (YoY)10.7%-19.0 p.p.29.8%-1.7 p.p.31.5%-13.4 p.p.44.9%——
Effective tax rate13.3%-0.6 p.p.14.0%+2.7 p.p.11.2%+93.9 p.p.-82.7%-78.1 p.p.-4.5%
Interest coverage1.54×-1.6%1.56×+5.4%1.48×-12.5%1.69×+92.0%0.88×

Newest column (“Last 12M”) = trailing 12 months, the last 4 reported quarters — shown with the quarter range it spans; earlier columns are full fiscal years.

Balance Sheet — Health & Leverage

MetricLast 12MQ3'25 – Q2'26Δ2025Δ2024Δ2023Δ2022
Net debt$2,343,216,418+3.3%$2,268,124,612+42.6%$1,590,281,811+13.0%$1,406,927,549+35.2%$1,040,366,915
Net Debt / Equity2.00×-9.0%2.19×+21.8%1.80×+33.7%1.35×+2.5%1.31×
Net Debt / EBITDA2.86×-12.1%3.25×-2.9%3.35×+25.2%2.67×-26.2%3.62×
Debt / Equity2.25×-7.4%2.43×+17.1%2.07×+32.6%1.56×-3.0%1.61×
Current ratio1.20×-8.8%1.32×-10.7%1.47×-1.2%1.49×-25.8%2.01×
Return on equity (ROE)11.6%+0.3 p.p.11.3%+3.3 p.p.8.0%-12.5 p.p.20.5%+22.6 p.p.-2.1%
Return on assets (ROA)3.3%+0.3 p.p.3.0%+0.6 p.p.2.4%-4.9 p.p.7.3%+8.0 p.p.-0.7%
Book value / share$1.91+11.2%$1.72+15.2%$1.49-15.5%$1.77+31.9%$1.34

Newest column (“Last 12M”) = trailing 12 months, the last 4 reported quarters — shown with the quarter range it spans; earlier columns are full fiscal years.

Net Debt & Leverage

Free Cash Flow

Margins

Dividend Payout Ratio

Capex ÷ Revenue

Cash Conversion (operating cash flow ÷ net income)

Ratios computed from company financial statements. Net Debt = total debt − cash & equivalents; FCF = operating cash flow − capital expenditure; absolute values in USD.

Valuation & Dividends

P/E Ratio History

Dividend History

Dividends and yield from Yahoo Finance (per ADR share, in US dollars). The current-year figures are calendar year-to-date (dividends actually paid this year), not the trailing 12 months.

Listings

SmartFit trades on 2 exchanges. Prices on this page are the OTC ADR (SFEGY).

ExchangeTickerCurrency
OTCpriced hereSFEGYUSD
B3 (São Paulo)SMFT3BRL

Frequently Asked Questions

Why hold SmartFit SFEGY ADR instead of local B3 SMFT3 shares?

Buying directly on Brazil’s B3 exchange means opening a local brokerage account, converting currency and dealing with Brazilian tax paperwork. ADRs remove that friction: they settle in dollars, follow US market hours, and report in formats foreign investors already understand.

The trade-off is that an ADR’s price reflects two moving parts: (1) the underlying share price, quoted in reais on the B3, and (2) the USD/BRL exchange rate. Because of that second part, a rising company can still deliver a flat, or even negative, dollar return if the real weakens against the dollar. The same applies to ETFs: funds such as EWZ, EWZS and FLBR bundle dozens of these companies into a single ticker for instant diversification, but their dollar value still moves with the real.

Where is SmartFit listed?

SmartFit trades on 2 exchanges. The line quoted on this page is OTC in the United States (SFEGY, US dollars). It also trades on B3 (São Paulo) in Brazil (SMFT3, Brazilian reais).

On how many exchanges does SmartFit trade?

2. OTC — SFEGY (USD) · B3 (São Paulo) — SMFT3 (BRL). Prices shown on this page are the OTC line, SFEGY.

What is SmartFit's primary listing?

SmartFit's primary listing is on the B3 in Brazil, where the shares trade as SMFT3 in reais — the company's home market. The OTC line quoted on this page is an ADR over those same shares: it gives you the asset in US dollars, on US market hours, without opening a Brazilian brokerage account or trading in reais.

What is the difference between SFEGY and SMFT3?

They are the same company and, economically, the same asset. SMFT3 is the original Brazilian share, listed on the B3 and quoted in reais. SFEGY is an American Depositary Receipt over that share, listed on the OTC and quoted in US dollars — a wrapper whose purpose is to give foreign investors access to the Brazilian asset without opening an account in Brazil. The SFEGY price therefore tracks two things: SMFT3 in reais, and the USD/BRL exchange rate.

How can I buy SmartFit stock in the United States?

SmartFit is listed on the OTC under SFEGY, priced in US dollars. Any US brokerage offering over-the-counter securities can trade it, with no foreign-account paperwork and no currency conversion.

As of Fri, Aug 14, 17:00 BRT · Market closed

Financial data last updated: August 11, 2026

← All stocks & ETFs